Atropine/2-PAM and naloxone/nalmefene - no cost extension to 31 OCT 2020

Ended Definitive Contract Awarded Last action

Contract number
W911QY17C0045
Awardee
Awarding agency
Obligated
$2,647,666

Award facts

Contract value 100% obligated
$2,647,665.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Boulder, CO, USA
Research
SBIR Program Phase II Action
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 $0
Supplemental Agreement for work within scope P00010 · Atropine/2-PAM and naloxone/nalmefene $0
Supplemental Agreement for work within scope P00009 · Diazepam studies $184,907
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 · Atropine/2-PAM and naloxone/nalmefene $141,911
Additional Work (new agreement, FAR part 6 applies) P00004 · Additional scope work order 1 & 2 $1,000,000
Additional Work (new agreement, FAR part 6 applies) P00003 · Monthly status reports $321,000
Other Administrative Action P00002 · 60 day no cost extension $0
Supplemental Agreement for work within scope P00001 · Monthly status reports $0
Original award $999,848
Show all 11

About this award

This is a $2,647,665.96 Firm Fixed Price federal contract awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Aktivax, Inc., a small business manufacturer, on March 8, 2017. The contract, which is set aside for small businesses, is for a SBIR (Small Business Innovation Research) Program Phase II effort with an ultimate completion date of October 31, 2020. The place of performance is Boulder, CO.

Quick answers

Who was awarded contract W911QY17C0045?

W911QY17C0045 was awarded to Aktivax, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on March 8, 2017.

How much is contract W911QY17C0045 worth?

The government has obligated $2,647,666 on W911QY17C0045.

Which agency awarded contract W911QY17C0045?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY17C0045, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY17C0045 competed?

The extent of competition for W911QY17C0045 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award